Clinical Trials Logo

Filter by:
NCT ID: NCT03710291 Terminated - Clinical trials for Chronic Kidney Disease

Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis

VALOR-CKD
Start date: November 20, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effect of TRC101 on the progression of chronic kidney disease (CKD) and to evaluate the safety profile of TRC101 in CKD patients with metabolic acidosis.

NCT ID: NCT03682055 Terminated - Clinical trials for Nasopharyngeal Carcinoma

Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)

Start date: April 4, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

VK-2019-001 is a 1/2a trial of the oral EBNA-1 targeting agent VK-2019 in patients with EBV-positive recurrent or metastatic NPC to determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D), as well as to evaluate the PK profile of VK-2019.

NCT ID: NCT03662841 Terminated - Clinical trials for Carcinoma, Hepatocellular

Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma

Start date: July 13, 2018
Phase: N/A
Study type: Interventional

The objective of this study is to study the safety and tumor response of ACE for large HCC.

NCT ID: NCT03654729 Terminated - Colorectal Cancer Clinical Trials

Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)

POLAR-M
Start date: November 7, 2018
Phase: Phase 3
Study type: Interventional

This study evaluates the investigational drug PledOx in the prevention of chronic chemotherapy induced peripheral neuropathy (CIPN) induced by the drug oxaliplatin.

NCT ID: NCT03610230 Terminated - Clinical trials for Iron Deficiency Anemia Treatment

Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

1. To compare patient-reported satisfaction, efficacy and short-term safety profile of Monofer® in a single bolus dose with Venofer® in split doses in the treatment of absolute or functional iron deficiency anemia in patients on PD. 2. To compare patient symptomatology on fatigue after treatment of Monofer® compared with Venofer® .

NCT ID: NCT03577899 Terminated - Clinical trials for Neovascular Age-related Macular Degeneration

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)

Start date: September 25, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this clinical study is to evaluate the efficacy and safety of two different levels of conbercept intravitreal (IVT) injection as compared to the approved vascular endothelial growth factor (VEGF) antagonist active control, aflibercept intravitreal injection (2.0 mg/eye, Eylea®), in subjects with neovascular AMD.

NCT ID: NCT03519256 Terminated - Clinical trials for Urinary Bladder Neoplasms

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

CheckMate 9UT
Start date: August 2, 2018
Phase: Phase 2
Study type: Interventional

A study to evaluate the safety and tolerability of nivolumab or nivolumab Plus BMS-986205 with or without BCG in BCG-Unresponsive non-muscle invasive Bladder Cancer.

NCT ID: NCT03515824 Terminated - Neoplasms Clinical Trials

Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001)

Start date: August 13, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and preliminary efficacy of MK-1697. There are 2 parts in this study: dose escalation to determine the recommended phase 2 dose (RP2D) and confirm the RP2D (Part A) and cohort expansion to determine preliminary efficacy in participants with colorectal cancer (CRC) or head and neck squamous cell cancer (HNSCC) (Part B). No formal hypothesis testing will be done in this study.

NCT ID: NCT03491150 Terminated - Alzheimer's Disease Clinical Trials

An Open-Label Crenezumab Study in Participants With Alzheimer's Disease

CREAD OLE
Start date: April 11, 2018
Phase: Phase 3
Study type: Interventional

In the BN40031 OLE study, a dose of crenezumab of 60 mg/kg intravenous (IV) every 4 weeks (Q4W) will be offered to all participants who complete Study BN29552 or BN29553 and who meet eligibility criteria in order to evaluate safety in participants on long-term crenezumab treatment and to investigate the effect of crenezumab on the underlying disease process and disease course as an exploratory efficacy objective.

NCT ID: NCT03454607 Terminated - Sinusitis Clinical Trials

Foot Controlled Robotic Endoscope Enabled Robot FESS

Start date: January 4, 2018
Phase: N/A
Study type: Interventional

To evaluate the safety and feasibility of a Foot Controlled Robotic Endoscope Enabled Robot (FREE) in performing functional endoscopic sinus surgery to answer the two key questions: 1. Is the FREE robot feasible to use in patients for endoscopic sinus surgery? 2. Is the FREE robot safe to use in patients for endoscopic sinus surgery?